Previous Close | 160.44 |
1-Year Change | 18.91% |
6-Months Change | 11.15% |
3-Months Change | 6.17% |
Moving Avg (50d) | 154 |
Moving Avg (200d) | 141.89 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 18.0B |
Beta (3-Years) | 0.45 |
Revenue Growth (ttm) | -9.69% |
Net Profit Margin (ttm) | 8.21% |
Return On Assets (ttm) | 5.66% |
EPS (ttm) | 6.71 |
PE Ratio (ttm) | 23.91 |
Dividend Yield | 1.74% |
Asset Description: | Quest Diagnostics Incorporated |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-10-28 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
164.546 | 169.386 | 172.612 | 177.452 | 185.518 | 193.584 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Life Sciences Tools & Services |
Country: | United States |
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access... Wikipedia